220503-89-9

Upstream product

• 220503-64-0 2′,3′,5′-tri-O-benzoyl-2′-C-methyl-N⁴-benzoylcytidine 
• 220503-84-4 3',5'-O-(di-tert-butylsilanediyl)-4-N-benzoyl-2'-C-β-methyl-2'-O-(tetrahydropyranyl)cytidine 
• 220503-65-1 3',5'-O-(di-tert-butylsilanediyl)-2'-C-β-methyl-4-N-benzoylcytidine 
• 220503-82-2 4-N-benzoyl-2-C-β-methylcytidine 
• 64339-87-3 N₄,O-bis(trimethylsilyl)-N₄-benzoylcytosine 
• 26661-13-2 4-N-benzoylcytosine 
• 40615-36-9 4,4'-dimethoxytrityl chloride 

Relevant academic research and scientific papers

2'-C-branched ribonucleosides: Synthesis of the phosphoramidite derivatives of 2'-C-β-methylcytidine and their incorporation into oligonucleotides

We describe a strategy for the incorporation of a 2'-C-branched ribonucleoside, 2'-C-β-methylcytidine, into oligonucleotides via solid- phase synthesis using phosphoramidite derivatives. 4-N-Benzoyl-2'-C-β- methylcytidine (2b) was synthesized by coupling persilylated 4-N- benzoylcytosine with 1,2,3,5-tetra-O-benzoyl-2-C-β-methyl-α-(and β)-D- ribofuranose (1) in the presence of SnCl4 in acetonitrile, followed by selective deprotection with NaOH in pyridine/methanol. The 3'- and 5'- hydroxyl groups were blocked as a cyclic di-tert-butylsilanediyl ether 3 by treatment with di-tert-butyldichlorosilane/AgNO3 in DMF. The 2'-hydroxyl group was then protected as a tert-butyldimethylsilyl ether 4a by treatment with tert-butylmagnesium chloride followed by addition of tert- butyldimethylsilyl trifluoromethanesulfonate in THF. As an alternative to 2'- silyl protection, the corresponding 2'O-tetrahydropyranyl ether 4b was prepared by treatment of 3 with 4,5-dihydro-2H-pyran in the presence of a catalytic amount of 10-camphorsulfonic acid in methylene chloride. The di- tert-butylsilanediyl groups of 4a and 4b were removed by treatment with pyridinium poly(hydrogen fluoride) to afford 5a and 5b, respectively. Protection of the 5'-hydroxyl group as a dimethoxytrityl ether and phosphitylation of the 3'-hydroxyl group by the standard procedure gave the phosphoramidite derivatives 7a and 7b. Both 7a and 7b could be used to incorporate 2'-C-β-methylcytidine into oligonucleotides efficiently via standard solid-phase synthesis, but the tetrahydropyranyl group of 7b was more readily removed from oligonucleotides than the tert-butyldimethylsilyl group of 7a. Oligonucleotides containing 2'-C-β-methylcytidine undergo base- catalyzed degradation analogous to natural RNA.